Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer

Strahlentherapie und Onkologie

Volumn 188, Issue 8, 2012, Pages 677-685

  Nguyen, N P ^a   Vock, J ^b   Chi, A ^a   Vinh Hung, V ^c   Dutta, S ^d   Ewell, L ^a   Jang, S ^e   Betz, M ^c   Almeida, F ^a   Miller, M ^a   Davis, R ^a   Sroka, T ^a   Vo, R P ^f   Karlsson, U ^g   Vos, P ^h  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d San Antonio Cancer Center   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f University of Galveston Medical School   (United States)

^g MARSHFIELD CLINIC   (United States)

^h EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Chemoradiation; Elderly; Head and neck cancer; Image guided radiotherapy; Intensity modulated radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMAGE GUIDED RADIOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARIZONA; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ORGANS AT RISK; OTORHINOLARYNGOLOGIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES;

EID: 84864592088     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0125-0     Document Type: Article

References (33)

1. Adelstein DJ, Adams GL, Wagner H et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21:92-98.
2. Alongi F, Bignardi M, Garassino I et al (2012) Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients. Strahlenther Onkol 188:49-55.
3. Berger NA, Savvides P, Koroukian SM et al (2006) Cancer in the elderly. Trans Am Clin Climatol Assoc 117:147-155.
4. Bernier J, Cooper JS, Pajak TF et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck 27:843-850. (Pubitemid 41395696)
5. Bonner JA, Harari PM, Giralt J et al (2006) Radiotherapy plus cetuximab for squamous cell carcinoma of the head and neck. N Engl J Med 354:567-578. (Pubitemid 43209104)
6. Bonner JA, Harari PM, Giralt J et al (2010) Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11:21-28.
7. Calais G, Alfonsi M, Bardet E et al (1999) Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharyngeal carcinoma. J Nat Cancer Inst 91:2081-2086. (Pubitemid 30019568)
8. Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. N Engl J Med 350:1937-1944.
9. Felts F, Kraft JW, Grabenbauer GG (2010) Geriatrie und Radioonkologie. Strahlenther Onkol 186:411-422.
10. Givens DJ, Karnell LH, Gupta AK et al (2009) Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancers. Arch Otolaryngol Head Neck Surg 135:1209-1217.
11. Goncalves Dias MC, Fatima Nunes Marucci M de, Nadalin W et al (2005) Nutritional intervention improves the caloric and protein ingestion of head and neck patients under radiotherapy. Nutr Hosp 20:320-325.
12. Huang SH, O'Sullivan B, Waldron J et al (2011) Pattern of care in elderly head and neck cancer radiation oncology patients: a single center cohort study. Int J Radiat Oncol Biol Phys 79:46-51.
13. Kodaira T, Fuwa N, Furutani K et al (2005) Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications. Jpn J Clin Oncol 35:173-176. (Pubitemid 40796849)
14. Le QT, Kim HE, Schneider CJ et al (2011) Palifermin reduces severe mucositis in definitive chemoradiotherapy for locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol 29:2808-2814.
15. Lewis JH, Kilgore ML, Goldman DP et al (2003) Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 21:1383-1389. (Pubitemid 46606420)
16. Maurer J, Hipp M, Schafer C et al (2011) Dyphagia. Impact on quality of life after radio(chemotherapy) of head and neck cancer. Strahlenther Onkol 187:744-749.
17. NCCN updates head neck cancer guidelines 2007. http://www.nccn.org. Accessed 15 May 2012.
18. Nguyen NP, Moltz CC, Frank C et al (2004) Dysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol 15:383-388. (Pubitemid 38444540)
19. Nguyen NP, Krafft SP, Vos P et al (2011) Feasibility of tomotherapy for Graves' ophthalmopathy: dosimetry comparison with conventional radiotherapy. Strahlenther Onkol 187:568-574.
20. Nguyen NP, Abraham D, Desai A et al (2011) Impact of image-guided radiotherapy to reduce laryngeal edema following treatment for non-laryngeal and non-hypopharyngeal head and neck cancers. Oral Oncol 47:900-904.
21. Nguyen NP, Ceizyk M, Vos P et al (2010) Effectiveness of image-guided radiotherapy for laryngeal sparing in head and neck cancer. Oral Oncol 46:283-286.
22. Nguyen NP, Moltz CC, Frank C et al (2007) Impact of swallowing therapy on aspiration rate following treatment for locally advanced head and neck cancer. Oral Oncol 43:352-357. (Pubitemid 46413983)
23. Nguyen NP, North D, Smith HJ et al (2006) Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol 15:199-203. (Pubitemid 46771192)
24. Posner MR, Hershock DM, Blajman CR et al (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705-1715. (Pubitemid 350005152)
25. Rasch CRN, Hauptmann M, Schornagel J et al (2010) Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer 116:2159-2165.
26. Sanabria A, Carvalho AL, Vartanian JG et al (2007) Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 14:1449-1457. (Pubitemid 46536825)
27. Semrau R, Temming S, Preuss SS et al (2011) Definitive radiochemotherapy of advanced head and neck cancer with carboplatin and paclitaxel. Strahlenther Onkol 187:645-650.
28. Sesterhenn AM, Teymoortash A, Folz BJ et al (2005) Head and neck cancer in the elderly: a cohort study in 40 patients. Acta Oncol 44:59-64. (Pubitemid 40249129)
29. Shrestha LB, Heisler EJ (2011) The changing demographic profile in the United States. Congressional Research Service 2011. http://www.crs.gov. Accessed 15 May 2012.
30. Silander E, Nyman J, Bove M et al (2012) Impact of prophylactic percutaneous endoscopic gastrostomy on malnutrition and quality of life in patients with head and neck cancer-A randomized study. Head Neck 34:1-9.
31. Soo KC, Tan EH, Wee J et al (2005) Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomized comparison. Br J Cancer 93:279-286. (Pubitemid 43080029)
32. Surveillance, Epidemiology, and End Results (SEER) Program. Prevalence data base 2007. http://www.seer.cancer.gov. Accessed 15 May 2012.
33. Walsh L, Gillham C, Dunne M et al (2011) Toxicity of cetuximab versus cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer. Radiother Oncol 98:38-41